Previous issue | Volume 92 | ESPE2019

58th Annual ESPE meeting

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

Card image cap
The theme of this year’s meeting is Variety and Variation in Paediatric Endocrinology. Join us in Vienna to explore the diversity we encounter in our discipline and the care that we have to exercise when using the term “normality”. Whilst gaining an update on the latest treatments, clinical best practice and cutting edge research in the field of paediatric endocrinology.

Rapid Free Communications

Adrenals and HP Axis

Children and Adolescents in the United States with Congenital Adrenal Hyperplasia are not at Increased Risk for Attention-Deficit/Hyperactivity Disorder
1University of Minnesota Medical School, Medical Scientist Training Program, Minneapolis, USA. 2University of Minnesota Medical School, Department of Pediatrics, Minneapolis, USA. 3National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, USA. 4University of Minnesota Masonic Children's Hospital, Divisions of Pediatric Endocrinology and Genetics & Metabolism, Minneapolis, USA
hrp0092rfc13.1
Development of Novel Non-Invasive Strategies for Monitoring of Treatment Control in Patients with Congenital Adrenal Hyperplasia
1Academic Unit of Child Health, Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom. 2Department of Biochemistry, Manchester University NHS Foundation Trust, Manchester, United Kingdom. 3Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom. 4Birmingham Women's & Children's Hospital, Birmingham, United Kingdom. 5Paediatric Endocrine Service, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom. 6Leeds General Infirmary, Leeds, United Kingdom. 7Nottingham Children's Hospital, Nottingham, United Kingdom. 8Centre for Endocrinology, William Harvey Research Institute, Queen Mary University London, London and Barts Health NHS Trust - The Royal London Hospital, London, United Kingdom. 9Great Ormond Street Hospital, London, United Kingdom. 10Great North Children's Hospital, University of Newcastle, Newcastle, United Kingdom. 11Developmental Endocrinology Research Group, University of Glasgow, Glasgow, United Kingdom. 12Institute of Metabolism and System Research, University of Birmingham, Birmingham, United Kingdom. 13Oxford Childrens Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom. 14Bristol Royal Hospital for Children, University Hospitals Bristol Foundation Trust, Bristol, United Kingdom. 15University Hospital Southampton, Southampton, United Kingdom
hrp0092rfc13.2
Establishment of Reference Intervals for Hair Cortisol in Healthy Children Aged 0-18 Years Using Mass Spectrometric Analysis
1St Antonius Hospital, Nieuwegein, Netherlands. 2Erasmus Medical Center, Rotterdam, Netherlands. 3Amsterdam University Medical Center, Amsterdam, Netherlands. 4University of Utrecht, Utrecht, Netherlands
hrp0092rfc13.3
Inhibitory Effects of Curcuminoids on the Enzymes from the Steroidogenic Pathway
1Pediatric Endocrinology, University Children's Hospital Bern, Bern, Switzerland. 2Department of BioMedical Research, University of Bern, Bern, Switzerland
hrp0092rfc13.6
PAPP-A2 Deficiency Results in Sex-Dependent Modifications in Hypothalamic Regulation of Energy Homeostasis
1Department of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain. 2Instituto de Investigación Biomédica de Málaga (IBIMA), UGC Salud Mental, Universidad de Málaga, Hospital Universitario Regional de Málaga, Málaga, Spain. 3 Simon Fraser University. Department of Biological Sciences, Burnaby, Canada. 4Hospital de la Princesa Research Institute, Madrid, Spain. 5Centro de Investigación Biomédica en Red de Fisiopatologia de la Obesidad y Nutriciòn (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. 6IMDEA Food Institute, CEI UAM + CSIC, Madrid, Spain
hrp0092rfc14.1
MicroRNAs Change and Target Key Regulatory Genes Involved in Longitudinal Growth in Patients with Idiopathic Isolated Growth Hormone Deficiency (IGHD) on Growth Hormone (GH) Treatment
1Department of Mother and ChildDepartment of Mother and Child, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy. 2Department of Mother and Child, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy. 3Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy. 4 Department of Medical and Surgical Sciences of the Mother, Children and Adults, Modena, Italy
hrp0092rfc14.3
GHR Transcript Heterogeneity May Explain the Phenotypic Variability in Patients with Homozygous GHR Pseudoexon (6ψ) Mutation
1Centre for Endocrinology, William Harvey Research Institute, Queen Mary University London, London, United Kingdom. 2Birmingham Heartland Hospital, Heart of England NHS Foundation Trust, Birmingham, United Kingdom. 3The Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom
hrp0092rfc14.4
Bioactive IGF-I Concentration Compared to Total IGF-I Concentration Before and After 1 Year of High-Dose Growth Hormone in Short Children Born Small for Gestational Age - North European SGA Study (NESGAS)
1Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 2Department of Pediatrics, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom. 3Department of Pediatrics, The National Children's Hospital, University of Dublin, Trinity College, Dublin, Ireland. 4Department of Endocrinology, Birmingham Children's Hospital, Birmingham, United Kingdom. 5Department of Clinical Sciences, Endocrine and Diabetes Unit, University of Lund, Malmoe, Sweden. 6Pediatric Endocrinology Unit, Department of Women's and Children's Health, Karolinska Institutet & University Hospital, Stockholm, Sweden. 7Department of Endocrinology, Odense University Hospital & Department of Clinical Research, University of Southern Denmark, Odense, Denmark
hrp0092rfc14.5